Andexanet alfa (PRT4445, Portola Pharmaceuticals) to the anticoagulant effects of the new oral factor Xa inhibitors reversed the effects of one such agent,apixaban (Eliquis, Bristol-Myers Squibb/Pfizer), by >90% within two minutes of an initial IV bolus and maintained that level throughout a two-hour infusion[1].

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()